Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Immunome Inc
IMNMCurrent price
8.40 USD
+0.06 USD (+0.72%)
Last closed
8.50 USD
Company
immunome.com
ISIN
US45257U1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
740 820 032 USD
Yield for 12 month
-39.22 %
1Y
3Y
5Y
10Y
15Y
IMNM
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises of AL102, a gamma secretase inhibitor which is in phase 3 clinical trial for the treatment of desmoid tumors; IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates which is in phase 1 clinical trial; and preclinical asset consist of IM-3050, a fibroblast activation protein targeted radioligand therapy. It also develops solid tumor ADC drug candidates which includes IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington. Address: 18702 N. Creek Parkway, Bothell, WA, United States, 98011
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
26.00 USDP/E ratio
–Dividend Yield
–Current Year
+9 041 000 USD
Last Year
+14 018 000 USD
Current Quarter
+2 738 000 USD
Last Quarter
+2 910 000 USD
Current Year
+9 041 000 USD
Last Year
-8 907 000 USD
Current Quarter
+2 738 000 USD
Last Quarter
+2 910 000 USD
Key Figures IMNM
1 year
3 years
5 years
10 years
EBITDA
-151 888 992 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-49.34 %
PEG Ratio
–
Return On Equity TTM
-194.63 %
Wall Street Target Price
26.00 USD
Revenue TTM
9 041 000 USD
Book Value
2.81 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-28.40 %
Dividend Yield
–
Gross Profit TTM
-120 501 000 USD
Earnings per share
-5.00 USD
Diluted Eps TTM
-5.00 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics IMNM
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History IMNM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio TTM
–
Last Split Date
–
Stock Valuation IMNM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
58.44
Price Sales TTM
81.94
Enterprise Value EBITDA
-0.72
Price Book MRQ
4.09
Financials IMNM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IMNM
For 52 weeks
5.15 USD
16.81 USD
50 Day MA
8.26 USD
Shares Short Prior Month
9 523 078
200 Day MA
11.59 USD
Short Ratio
8.82
Shares Short
11 132 992
Short Percent
13.31 %
BeatStart